Yasutaka Okita

13PUBLICATIONS
49CO-AUTHORS
Clinical pharmacology and therapeuticsMetabolic medicineRheumatology and arthritisRespiratory diseasesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 01, 2026
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort.

Yuki Etani, Yasutaka Okita, Kohei Tsujimoto

|Jul 01, 2025
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort Study.

Kosuke Ebina, Yuki Etani, Yasutaka Okita

|Mar 20, 2025
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.

Kohei Tsujimoto, Kosuke Ebina, Satomi Okamura

|Mar 19, 2025
Distinct impact of RF and ACPA titre on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort study.

Yuki Etani, Yasutaka Okita, Yuichi Maeda

|Oct 30, 2024
Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritis.

Nozomi Nishimura, Akira Onishi, Wataru Yamamoto

|Nov 21, 2023
Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritis.

Akira Onishi, Hirotaka Yamada, Wataru Yamamoto

Pageof 3

Frequent Collaborators

9 joint publications

Motomu Hashimoto

7 joint publications

Atsushi Kumanogoh

7 joint publications

Akira Onishi

6 joint publications

Kosuke Ebina